Anthrax  >>  Abthrax (raxibacumab)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Abthrax (raxibacumab) / Emergent Biosolutions
NCT02016963: An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection

Completed
2/3
20
NA
Raxibacumab
Human Genome Sciences Inc., GlaxoSmithKline, Emergent BioSolutions
Therapeutic Treatment of Inhalation Anthrax
05/08
05/08

Download Options